(Q34565716)

3 August 2017

1 reference

title

Radiation therapy for hepatocellular carcinoma: from palliation to cure (English)

1 reference

adaptive radiation therapy

3 August 2017

main subject

0 references

hepatocellular carcinoma

1 reference

Maria A Hawkins

1

0 references

Laura A. Dawson

object named as

Laura A Dawson

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 April 2006

1 reference

3 August 2017

1 reference

3 August 2017

volume

106

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

1653-1663

1 reference

Stereotactic radiation therapy of liver metastases: update of the initial phase-I/II trial

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

Brain metastasis of hepatocellular carcinoma: A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Treatment strategies for hepatocellular carcinoma in cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Hepatic resection versus transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Role of adjuvant treatment in liver transplantation for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Comparison of Clinicopathologic Characteristics and Outcomes After Resection in Patients With Hepatocellular Carcinoma Treated in the United States, France, and Japan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Surgical therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

High-intensity focused ultrasound in the treatment of solid tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Hepatic toxicity resulting from cancer treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Organ and tumor motion: an overview

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Yttrium-90 Microspheres: Radiation Therapy for Unresectable Liver Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Radiotherapy for painful bone metastases from hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Intracranial metastasis of hepatocellular carcinoma: review of 45 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Radiation therapy for adrenal gland metastases from hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Daily targeting of intrahepatic tumors for radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Partial volume tolerance of the liver to radiation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Local radiotherapy for patients with unresectable hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Dose-response relationship in local radiotherapy for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Focused radiation hepatitis after Bragg-peak proton therapy for hepatocellular carcinoma: CT findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Analysis of radiation-induced liver disease using the Lyman NTCP model.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21811

7 January 2021

Identifiers

DOI

10.1002/CNCR.21811

1 reference

3 August 2017

1 reference